Another recent meta-analysis focused on PET/MR with 68Ga-PSMA-targeted agents [40] found that this method is likely effective in the diagnosis of primary PCa, and its diagnostic accuracy BR-PCa was positively correlated to serum PSA levels: The pooled sensitivity and specificity in detecting primary PCa were 83% and 81%, respectively; in BR-PCa, the pooled detection rate was 76%. The gene discussed is FOLH1; the disease is posterior cortical atrophy.